Group boss grants recruits
Release time:
2020-08-14
Group boss awarded recruits
News 8# July 2 to 4 , the company's newly recruited 30 new employees attended induction training at the group headquarters. During the three-day training, Chairman Jiang Xiaomeng, General Manager Yu Jianhong and other group company leaders and heads of relevant enterprises and departments gave lectures to them.
Chairman Jiang Xiaomeng gave the first lesson of induction training to new employees on the topic of "How to Grow with the Enterprise. He said that employees are the main members of the company's wealth creation and the core competitiveness of the company's development. The key to the success of the company lies in selecting, retaining, educating, and employing people. Based on his own experience and the current market situation, Jiang Xiaomeng analyzed the factors of success in life, the signs of a successful career, and the core elements of his personal career. He hoped that new employees would adjust their mentality in time, strengthen their learning, cultivate the values of honesty and integrity, and deal with things with win-win thinking. Establish a universal personal knowledge management system, make objective self-assessment, clear goals, formulate a reasonable personal vision, and seize opportunities, maximize success in life.
General Manager Yu Jianhong introduced the company's basic situation, future development plan and development strategy from the four major sectors of cement, medicine, health and other industries; from the four stages of hard work, determined reform, diversified development and strategic adjustment, he described the development process of the peak; this paper systematically expounds the profound connotation of peak enterprise culture from the aspects of enterprise spirit, vision, development concept, values, talent concept, business philosophy and work style, and explains how to realize personal value and how to do a good job in personal career planning. He hopes that new employees will objectively evaluate themselves, fully understand the current environment and trends, keep a clear mind, be prepared for difficulties, setbacks and pressures, become talents as soon as possible, and contribute their strength to the realization of the "century peak" vision.
In order to enable new employees to integrate into the enterprise better and faster, in addition to the lectures given by the chairman and general manager, Tang Zhengren, manager of the human resources department of the group company, explained the enterprise rules and regulations and the employee handbook in detail for the new employees. Jin Huazhong, secretary of the party Committee of the pharmaceutical company, and Lou Weijin, director of safety of the group, respectively taught professional ethics and safety knowledge. During the training, they also visited the company's exhibition hall and had a deeper understanding of the entrepreneurial development and corporate culture of the peak. (Reporter Ni Yingzhen)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31